PD-1 inhibitors in esophageal cancer: a systematic review of the oncological outcomes associated with PD-1 blockade and the evolving therapeutic paradigm

Abstract Patients with esophageal or gastroesophageal junction (GEJ) cancer who fail to respond to chemoradiotherapy have a poor clinical prognosis. Recent clinical trials have investigated the use of immune checkpoint inhibitors in these patients. The use of programmed cell death protein 1 (PD-1) i...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diseases of the esophagus 2022-05, Vol.35 (5)
Hauptverfasser:	Whooley, J, Alazzawi, M, Donlon, N E, Bolger, J C, Robb, W B
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!